MT-SLP-76-overexpressing CD22 CAR T cells mediated sustained tumor eradication, whereas CD22 CAR T cells alone induced only modest tumor control (Fig. 3a–c and Extended Data Fig. 3a). The gene discussed is CD22; the disease is neoplasm.